Isolated limb perfusion for an irresectable melanoma recurrence in a Jehovah's witness

European Journal of Cardio-thoracic Surgery

Volumn 30, Issue 2, 2006, Pages 408-410

  van Akkooi, Alexander C J ^a   Golab Schwarz, Hannah D ^a   Eggermont, Alexander M M ^a   van Geel, Albertus N ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Extracorporeal circulation; Isolated limb perfusion; Jehovah's witness; Melanoma; Surgery

Indexed keywords

ERYTHROPOIETIN; HEMOGLOBIN; HEPARIN; MELPHALAN; PROTAMINE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CANCER SURGERY; CANCER THERAPY; CASE REPORT; DEVICE; EXTRACORPOREAL CIRCULATION; EXTRACORPOREAL OXYGENATION; FEMALE; FEMUR; HEMOGLOBIN DETERMINATION; HOSPITAL DISCHARGE; HUMAN; ISOLATED LIMB PERFUSION; JEHOVAH'S WITNESS; LIMB BLOOD FLOW; MELANOMA; POSTOPERATIVE THROMBOSIS; PREOPERATIVE CARE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RECURRENT CANCER; TIBIA; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; TREATMENT OUTCOME;

BLOOD TRANSFUSION; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; FEMALE; HUMANS; JEHOVAH'S WITNESSES; MELANOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; SKIN NEOPLASMS;

EID: 33745917054     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2006.04.020     Document Type: Article

References (10)

1. Eggermont A.M. Treatment of melanoma in-transit metastases confined to the limb. Cancer Surv 26 (1996) 335-349
2. Creech Jr. O., Krementz E.T., Ryan R.F., and Winblad J.N. Chemotherapy of cancer: regional perfusion utilizing an extracorporeal circuit. Ann Surg 148 (1958) 616-632
3. Eggermont A.M., de Wilt J.H., and ten Hagen T.L. Current uses of isolated limb perfusion in the clinic and a model system for new strategies. Lancet Oncol 4 (2003) 429-437
4. Grunhagen D.J., Brunstein F., Graveland W.J., van Geel A.N., de Wilt J.H., and Eggermont A.M. One hundred consecutive isolated limb perfusions with TNF-alpha and melphalan in melanoma patients with multiple in-transit metastases. Ann Surg 240 (2004) 939-947 [discussion 947-38]
5. de Wilt J.H., ten Hagen T.L., de Boeck G., van Tiel S.T., de Bruijn E.A., and Eggermont A.M. Tumour necrosis factor alpha increases melphalan concentration in tumour tissue after isolated limb perfusion. Br J Cancer 82 (2000) 1000-1003
6. Vaislic C., Bical O., Deleuze P., Khoury W., Gaillard D., Ponzio O., Ollivier Y., Robine B., Dupuys C., and Sportiche M. Cardiac surgery without transfusion in 2005. Arch Mal Coeur Vaiss 98 (2005) 7-12
7. Bonhomme V., Damas F., Born J.D., and Hans P. Perioperative management of blood loss during surgical treatment for craniosynostosis. Ann Fr Anesth Reanim 21 (2002) 119-125
8. Lanzinger M.J., Niklason L.E., Shannon M., and Hill S.E. Use of hemoglobin raffimer for postoperative life-threatening anemia in a Jehovah's witness [L'usage d'un raffimere d'hemoglobine en cas d'anemie postoperatoire grave chez un temoin de Jehovah]. Can J Anaesth 52 (2005) 369-373
9. Forest R.J., Groom R.C., Quinn R., Donnelly J., and Clark C. Repair of hypoplastic left heart syndrome of a 4.25-kg Jehovah's witness. Perfusion 17 (2002) 221-225
10. Gombotz H., Rigler B., Matzer C., Metzler H., Winkler G., and Tscheliessnigg K.H. 10 years' experience with heart surgery in Jehovah's witnesses. Anaesthesist 38 (1989) 385-390